141 related articles for article (PubMed ID: 2981982)
1. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
Dhingra HM; Valdivieso M; Carr DT; Chiuten DF; Farha P; Murphy WK; Spitzer G; Umsawasdi T
J Clin Oncol; 1985 Feb; 3(2):176-83. PubMed ID: 2981982
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
[TBL] [Abstract][Full Text] [Related]
3. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
Elliott JA; Ahmedzai S; Hole D; Dorward AJ; Stevenson RD; Kaye SB; Banham SW; Stack BH; Calman KC
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1025-32. PubMed ID: 6540685
[TBL] [Abstract][Full Text] [Related]
4. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
Fukuoka M; Masuda N; Furuse K; Negoro S; Takada M; Matsui K; Takifuji N; Kudoh S; Kawahara M; Ogawara M
J Clin Oncol; 1991 Apr; 9(4):606-13. PubMed ID: 1648597
[TBL] [Abstract][Full Text] [Related]
6. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
Masuda N
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
Drings P; Manke HG
Strahlentherapie; 1985 Mar; 161(3):131-3. PubMed ID: 2983459
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
[TBL] [Abstract][Full Text] [Related]
9. A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
Kodani T; Ueoka H; Kiura K; Tabata M; Takigawa N; Segawa Y; Moritaka T; Hiraki S; Harada M; Tanimoto M
Lung Cancer; 2002 Jun; 36(3):313-9. PubMed ID: 12009244
[TBL] [Abstract][Full Text] [Related]
10. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
Klastersky J; Sculier JP; Nicaise C; Weerts D; Mairesse M; Libert P; Rocmans P; Michel J; Ferremans W
Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
Murray N; Coppin C; Coldman A; Pater J; Rapp E
J Clin Oncol; 1994 Nov; 12(11):2333-9. PubMed ID: 7964949
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Gatzemeier U; Heckmayr M; Hossfeld DK; Kaukel E; Koschel G; Neuhauss R
Am J Clin Oncol; 1991 Oct; 14(5):405-11. PubMed ID: 1659174
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
König HJ; Arnold E; Walter M; Sander U
Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Ruckdeschel JC; Finkelstein DM; Ettinger DS; Creech RH; Mason BA; Joss RA; Vogl S
J Clin Oncol; 1986 Jan; 4(1):14-22. PubMed ID: 3510278
[TBL] [Abstract][Full Text] [Related]
16. [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
Gatzemeier U; Zschaber R; Hossfeld DK; Radenbach D
Onkologie; 1984 Oct; 7(5):308-15. PubMed ID: 6392971
[TBL] [Abstract][Full Text] [Related]
17. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
Fuks JZ; Patel H; Van Echo DA; Hornedo J; Aisner J
Med Pediatr Oncol; 1985; 13(2):73-7. PubMed ID: 4039026
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
Hainsworth JD; Porter LL; Johnson DH; Hande KR; Wolff SN; Birch R; Enas G; Greco FA
Cancer Treat Rep; 1986 Mar; 70(3):339-41. PubMed ID: 3955545
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tominaga K; Sakurai M; Suga J; Miyaoka H; Sano T; Keicho N
Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
